0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glaucoma"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
EUR$89USDGBP
EUR$104USDGBP
EUR$177USDGBP
EUR$600USDGBP
EUR$177USDGBP
EUR$231USDGBP
EUR$85USDGBP
EUR$119USDGBP
EUR$114USDGBP
EUR$236USDGBP
EUR$165USDGBP
EUR$85USDGBP
Glaucoma. Edition No. 2 - Product Thumbnail Image

Glaucoma. Edition No. 2

  • Book
  • September 2014
EUR$395USDGBP
EUR$281USDGBP
EUR$2,986USDGBP
Loading Indicator

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss. Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more